Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Ruth De Francisco"'
Autor:
Celia Gómez-Labrador, Elena Ricart, Marisa Iborra, Eva Iglesias, María Dolores Martín-Arranz, Luisa de Castro, Ruth De Francisco, Francisco Javier García-Alonso, Ana Sanahuja, Carla J. Gargallo-Puyuelo, Francisco Mesonero, María José Casanova, Míriam Mañosa, Montserrat Rivero, Marta Calvo, Mónica Sierra-Ausin, Carlos González-Muñoza, Xavier Calvet, Santiago García-López, Jordi Guardiola, Lara Arias García, Lucía Márquez-Mosquera, Ana Gutiérrez, Yamile Zabana, Mercè Navarro-Llavat, Rufo Lorente Poyatos, Marta Piqueras, Leyanira Torrealba, Fernando Bermejo, Ángel Ponferrada-Díaz, José L. Pérez-Calle, Manuel Barreiro-de Acosta, Coral Tejido, José Luis Cabriada, Ignacio Marín-Jiménez, Óscar Roncero, Yolanda Ber, Luis Fernández-Salazar, Blau Camps Aler, Alfredo J. Lucendo, Jordina Llaó, Luis Bujanda, Carmen Muñoz Villafranca, Eugeni Domènech, María Chaparro, Javier P. Gisbert
Publikováno v:
Pharmaceutics, Vol 16, Iss 5, p 629 (2024)
Markers that allow for the selection of tailored treatments for individual patients with inflammatory bowel diseases (IBD) are yet to be identified. Our aim was to describe trends in real-life treatment usage. For this purpose, patients from the ENEI
Externí odkaz:
https://doaj.org/article/07a5bfcf65344f8daf0648e08c7a639c
Autor:
Maria Puig, Helena Masnou, Francisco Mesonero, Luís Menchén, Luís Bujanda, Jesús Castro, Irene González-Partida, Raquel Vicente, Carlos González-Muñoza, Marisa Iborra, Mónica Sierra, José María Huguet, María José García, Ruth De Francisco, Francisco Javier García-Alonso, Míriam Mañosa, Eugeni Domènech, on behalf of ENEIDA-GETECCU Registry
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 23, p 7366 (2023)
Background: Thromboembolic events are frequent among patients with inflammatory bowel disease (IBD). However, there is little information on the prevalence, features and outcomes of splanchnic vein thrombosis (SVT) in patients with IBD. Aims: To desc
Externí odkaz:
https://doaj.org/article/70342e4358064a099eaeb73afe293550
Autor:
Ana Gutiérrez, Pedro Zapater, Elena Ricart, María González-Vivó, Jordi Gordillo, David Olivares, Isabel Vera, Míriam Mañosa, Javier P. Gisbert, Mariam Aguas, Eugenia Sánchez-Rodríguez, Maia Bosca-Watts, Viviana Laredo, Blau Camps, Ignacio Marín-Jiménez, Yamile Zabana, María Dolores Martín-Arranz, Roser Muñoz, Mercè Navarro, Eva Sierra, Lucía Madero, Milagros Vela, José Lázaro Pérez-Calle, Empar Sainz, Xavier Calvet, Lara Arias, Victor Morales, Fernando Bermejo, Luis Fernández-Salazar, Manuel Van Domselaar, Luisa De Castro, Cristina Rodríguez, Carmen Muñoz-Villafranca, Rufo Lorente, Montserrat Rivero, Eva Iglesias, Belén Herreros, David Busquets, Joan Riera, María Pilar Martínez-Montiel, Marta Roldón, Oscar Roncero, Esther Hinojosa, Mónica Sierra, Jesús Barrio, Ruth De Francisco, José Huguet, Olga Merino, Daniel Carpio, Daniel Ginard, Fernando Muñoz, Marta Piqueras, Pedro Almela, Federico Argüelles-Arias, Guillermo Alcaín, Luis Bujanda, Noemí Manceñido, Alfredo J. Lucendo, Pilar Varela, Iago Rodríguez-Lago, Laura Ramos, Laura Sempere, Eva Sesé, Manuel Barreiro-de Acosta, Eugeni Domènech, Rubén Francés
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundPrevious studies comparing immigrant ethnic groups and native patients with IBD have yielded clinical and phenotypic differences. To date, no study has focused on the immigrant IBD population in Spain.MethodsProspective, observational, mult
Externí odkaz:
https://doaj.org/article/d35e6ff2cdf74ae5a842b5e0dd987f1c
Autor:
Ivan Guerra, Luis Bujanda, Miriam Mañosa, Isabel Pérez-Martínez, María José Casanova, Luisa de la Peña, Marina de Benito, Montserrat Rivero, Pilar Varela, Lorena Bernal, Ana Carolina Franco, Yolanda Ber, Marta Piqueras, Carlos Tardillo, Ángel Ponferrada, Sonsoles Olivares, Alfredo J. Lucendo, Pau Gilabert, Mónica Sierra Ausín, María Bellart, Amaia Herrarte, Margalida Calafat, Ruth de Francisco, Javier P. Gisbert, Jordi Guardiola, Eugeni Domènech, Fernando Bermejo
Publikováno v:
Cancers, Vol 15, Iss 3, p 750 (2023)
An increased risk of lymphoma has been described in patients with inflammatory bowel disease (IBD). The aims of our study were to determine the clinical presentation, the previous exposure to immunosuppressive and biologic therapies, and the evolutio
Externí odkaz:
https://doaj.org/article/d7733158a52b471c906061627750146a
Autor:
María Chaparro, Iria Baston-Rey, Estela Fernández Salgado, Javier González García, Laura Ramos, María Teresa Diz-Lois Palomares, Federico Argüelles-Arias, Eva Iglesias Flores, Mercedes Cabello, Saioa Rubio Iturria, Andrea Núñez Ortiz, Mara Charro, Daniel Ginard, Carmen Dueñas Sadornil, Olga Merino Ochoa, David Busquets, Eduardo Iyo, Ana Gutiérrez Casbas, Patricia Ramírez de la Piscina, Marta Maia Boscá-Watts, Maite Arroyo, María José García, Esther Hinojosa, Jordi Gordillo, Pilar Martínez Montiel, Benito Velayos Jiménez, Cristina Quílez Ivorra, Juan María Vázquez Morón, José María Huguet, Yago González-Lama, Ana Isabel Muñagorri Santos, Víctor Manuel Amo, María Dolores Martín Arranz, Fernando Bermejo, Jesús Martínez Cadilla, Cristina Rubín de Célix, Paola Fradejas Salazar, Antonio López San Román, Nuria Jiménez, Santiago García-López, Anna Figuerola, Itxaso Jiménez, Francisco José Martínez Cerezo, Carlos Taxonera, Pilar Varela, Ruth de Francisco, David Monfort, Gema Molina Arriero, Alejandro Hernández-Camba, Francisco Javier García Alonso, Manuel Van Domselaar, Ramón Pajares-Villarroya, Alejandro Núñez, Francisco Rodríguez Moranta, Ignacio Marín-Jiménez, Virginia Robles Alonso, María del Mar Martín Rodríguez, Patricia Camo-Monterde, Iván García Tercero, Mercedes Navarro-Llavat, Lara Arias García, Daniel Hervías Cruz, Sebastian Kloss, Alun Passey, Cynthia Novella, Eugenia Vispo, Manuel Barreiro-de Acosta, Javier P. Gisbert
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 15, p 4518 (2022)
Ustekinumab has shown efficacy in Crohn’s Disease (CD) patients. To identify patient profiles of those who benefit the most from this treatment would help to position this drug in the therapeutic paradigm of CD and generate hypotheses for future tr
Externí odkaz:
https://doaj.org/article/bbc704ff26a449c5831cf6c241ff6dbe
Autor:
Sabino Riestra, Carlos Taxonera, Yamile Zabana, Daniel Carpio, María Chaparro, Jesús Barrio, Montserrat Rivero, Antonio López-Sanroman, María Esteve, Ruth de Francisco, Guillermo Bastida, Santiago García-López, Miriam Mañosa, María Dolores Martin-Arranz, José Lázaro Pérez-Calle, Jordi Guardiola, Fernando Muñoz, Laura Arranz, José Luis Cabriada, Mariana Fe García-Sepulcre, Mercè Navarro, Miguel Ángel Montoro-Huguet, Elena Ricart, Fernando Bermejo, Xavier Calvet, Marta Piqueras, Esther Garcia-Planella, Lucía Márquez, Miguel Mínguez, Manuel Van Domselar, Luis Bujanda, Xavier Aldeguer, Beatriz Sicilia, Eva Iglesias, Guillermo Alcaín, Isabel Pérez-Martínez, Valeria Rolle, Andrés Castaño-García, Javier P. Gisbert, Eugeni Domènech, on behalf of the ENEIDA registry from GETECCU
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 13, p 3915 (2022)
(1) Aims: Patients receiving antitumor necrosis factor (anti-TNF) therapy are at risk of developing tuberculosis (TB), usually due to the reactivation of a latent TB infection (LTBI). LTBI screening and treatment decreases the risk of TB. This study
Externí odkaz:
https://doaj.org/article/d42e2872dbab452290c46b2afed81491
Autor:
Sabino Riestra, Ruth de Francisco, Miguel Arias-Guillén, Cristina Saro, María García-Alvarado, José M. Duque, Juan José Palacios, Fernando Muñoz, Lorena Blanco, Olegario Castaño, Isabel Pérez-Martínez, Pablo Martínez-Camblor, Dolores Pérez-Hernández, Adolfo Suárez
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 108, Iss 9, Pp 541-549
Aims: To determine risk factors for active tuberculosis in patients with inflammatory bowel diseases. Methods: Retrospective, case-control study at 4 referral hospitals in Spain. Cases developed tuberculosis after a diagnosis of inflammatory bowel di
Externí odkaz:
https://doaj.org/article/0b7a86ef033b4a368b8d130d304ce33d
Publikováno v:
In FMC. Formación médica continuada en atención primaria April 2019 26(4):195-204
Autor:
María José Casanova, Óscar Nantes, Pilar Varela, Milagros Vela‐González, Montserrat Rivero, Olivia Sierra‐Gabarda, Sabino Riestra, Manuel Barreiro‐de Acosta, María del Mar Martín‐Rodríguez, Carla Jerusalén Gargallo‐Puyuelo, Cristina Reygosa, Roser Muñoz, Irene García de la Filia‐Molina, Andrea Núñez‐Ortiz, Lilyan Kolle, Margalida Calafat, José María Huguet, Eva Iglesias‐Flores, Teresa de Jesús Martínez‐Pérez, Orencio Bosch, José María Duque‐Alcorta, Santiago Frago‐Larramona, Manuel Van Domselaar, Víctor Manuel González‐Cosano, Luis Bujanda, Saioa Rubio, Alejo Mancebo, Beatriz Castro, Santiago García‐López, Ruth de Francisco, Laura Nieto‐García, Viviana Laredo, Ana Gutiérrez‐Casbas, Francisco Mesonero, Eduardo Leo‐Carnerero, Fiorella Cañete, Lucía Ruiz, Beatriz Gros, María del Moral‐Martínez, Cristina Rodríguez, María Chaparro, Javier P. Gisbert
Publikováno v:
Alimentary Pharmacology & Therapeutics.
Autor:
Manuel Barreiro-de, Acosta, Agnès, Fernández-Clotet, Francisco, Mesonero, Francisco Javier, García-Alonso, María José, Casanova, Margarita, Fernández-de la Varga, Fiorella, Cañete, Luisa, de Castro, Ana, Gutiérrez, Beatriz, Sicilia, Victoria, Cano, Olga, Merino, Ruth, de Francisco, Irene, González-Partida, Gerard, Surís, Leyanira, Torrealba, Rocío, Ferreiro-Iglesias, Beatriz, Castro, Lucía, Márquez, Ana, Sobrino, Ainara, Elorza, Xavier, Calvet, Pilar, Varela, Raquel, Vicente, Luis, Bujanda, Laura, Lario, Noemí, Manceñido, Mariana F, García-Sepulcre, Eva, Iglesias, Cristina, Rodríguez, Marta, Piqueras, Juan Ángel, Ferrer Rosique, Alfredo J, Lucendo, Olga, Benítez, Melody, García, David, Olivares, Carlos, González-Muñoza, Beatriz, López-Cauce, Victor Jair, Morales Alvarado, Katerina, Spicakova, Alicia, Brotons, Fernando, Bermejo, Pedro, Almela, Nahia, Ispízua, Pau, Gilabert, Carlos, Tardillo, Fernando, Muñoz, Pablo, Navarro, Rosa Eva, Madrigal Domínguez, Pau, Sendra, Esther, Hinojosa, Empar, Sáinz, María Dolores, Martín-Arranz, Daniel, Carpio, Elena, Ricart, Berta, Caballol, Laura, Núñez, Jesús, Barrio, Javier P, Gisbert, Marisa, Iborra, Margalida, Calafat, Vicent, Hernández, Roser Muñoz, Pérez, José Luis, Cabriada, Eugeni, Domènech, Iago, Rodríguez-Lago
Publikováno v:
American Journal of Gastroenterology.
The prevalence of penetrating complications in Crohn's disease (CD) increases progressively over time, but evidence on the medical treatment in this setting is limited. The aim of this study was to evaluate the effectiveness of biologic agents in CD